Tokushima, Japan

Fusahiro Higashitani


Average Co-Inventor Count = 8.9

ph-index = 3

Forward Citations = 57(Granted Patents)


Company Filing History:


Years Active: 1997-1999

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Fusahiro Higashitani: Innovating in β-Lactamase Inhibitors

Introduction: Fusahiro Higashitani, an accomplished inventor based in Tokushima, Japan, has made significant contributions to the field of pharmaceuticals. With three patents to his name, he specializes in developing innovative compounds aimed at combating antibiotic resistance.

Latest Patents: Higashitani's latest patents focus on azetidinone derivatives that act as potent β-lactamase inhibitors. One of his notable inventions is a new series of 2-oxo-1-azetidine sulfonic acid derivatives, which feature an aminoalkyl substituted 'anti' (E-isomer) oxyimino group at the acylamino substituent in the 3 position of the monobactam ring. These compounds have been proven to effectively inhibit bacterial β-lactamases, thereby enhancing the efficacy of β-lactam antibiotics against infections caused by β-lactamase producing bacteria.

Career Highlights: Throughout his career, Fusahiro Higashitani has been associated with prominent companies such as Synphar Laboratories, Inc. and Taiho Pharmaceutical Company Limited. His work in these organizations has contributed to advancements in antibiotic treatments and pharmaceutical innovations.

Collaborations: Higashitani has collaborated with esteemed colleagues, including Samarendra N Maiti and Oludotun A Phillips. Together, they have worked on various projects aimed at enhancing the effectiveness of antibiotics, showcasing the collaborative spirit that drives innovation in the pharmaceutical industry.

Conclusion: Fusahiro Higashitani continues to be a significant figure in the field of pharmaceutical research. His innovative work on β-lactamase inhibitors not only advances the scientific community's understanding but also plays a crucial role in addressing the challenges posed by antibiotic resistance. His patents will likely have a lasting impact on the treatment of bacterial infections in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…